The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Kite, a Gilead company; Spectrum Pharmaceuticals
Speakers' Bureau - AstraZeneca; Gilead Sciences; Kite, a Gilead company
Research Funding - Bristol-Myers Squibb; Epizyme; Incyte; Merck; Roche; Seagen
 
Research Funding - Celgene
Phase 2 study of parsaclisib (INCB050465) for relapsed or refractory diffuse large b-cell lymphoma (DLBCL) (CITADEL-202).
 
Morton Coleman
Stock and Other Ownership Interests - Kite, a Gilead company
Consulting or Advisory Role - Bayer; Celgene; Gilead Sciences
Speakers' Bureau - Bayer; Celgene; Gilead Sciences; Pharmacyclics
Research Funding - Bayer; Celgene; Gilead Sciences; Incyte; Merck
 
David Belada
No Relationships to Disclose
 
René-Olivier Casasnovas
Honoraria - Abbvie; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; Roche/Genentech; Takeda
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Roche/Genentech; Takeda
 
Rémy Gressin
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene; Pfizer; Sandoz
 
Hui-Peng Lee
No Relationships to Disclose
 
Amitkumar Mehta
No Relationships to Disclose
 
Javier Munoz
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - AstraZeneca; Bayer; Gilead Sciences; Kite, a Gilead company; Pharmacyclics/Janssen
 
Gregor Verhoef
No Relationships to Disclose
 
Claudia Corrado
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Douglas James DeMarini
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Wanying Zhao
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Xuejun Chen
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Keith Fay
Research Funding - Incyte